IRIS
DI MARIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.312
EU - Europa 11.551
AS - Asia 11.377
AF - Africa 200
SA - Sud America 152
Continente sconosciuto - Info sul continente non disponibili 60
OC - Oceania 44
Totale 44.696
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.982
CN - Cina 6.313
IE - Irlanda 3.612
SG - Singapore 3.330
SE - Svezia 3.246
TR - Turchia 1.427
UA - Ucraina 1.202
FI - Finlandia 1.060
DE - Germania 825
IT - Italia 718
CA - Canada 320
GB - Regno Unito 300
CI - Costa d'Avorio 171
BE - Belgio 141
BR - Brasile 136
IN - India 118
FR - Francia 62
NL - Olanda 60
EU - Europa 59
AT - Austria 56
RO - Romania 45
AU - Australia 42
RU - Federazione Russa 41
IR - Iran 37
LT - Lituania 34
CZ - Repubblica Ceca 31
HU - Ungheria 24
JP - Giappone 22
HK - Hong Kong 20
KR - Corea 20
ES - Italia 14
EG - Egitto 13
BG - Bulgaria 12
PL - Polonia 12
IL - Israele 10
SK - Slovacchia (Repubblica Slovacca) 10
ID - Indonesia 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
HR - Croazia 7
IQ - Iraq 6
RS - Serbia 6
VN - Vietnam 6
BD - Bangladesh 5
CL - Cile 5
EC - Ecuador 5
PH - Filippine 5
PT - Portogallo 5
UZ - Uzbekistan 5
EE - Estonia 4
LU - Lussemburgo 4
PA - Panama 4
TW - Taiwan 4
GR - Grecia 3
MD - Moldavia 3
MX - Messico 3
TN - Tunisia 3
ZA - Sudafrica 3
AR - Argentina 2
AZ - Azerbaigian 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
LK - Sri Lanka 2
LY - Libia 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CR - Costa Rica 1
GE - Georgia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
SM - San Marino 1
SN - Senegal 1
TG - Togo 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 44.696
Salva come PNG Salva come JPEG
Città #
Chandler 4.808
Dublin 3.604
Singapore 2.574
Santa Clara 2.073
Dearborn 1.619
Nanjing 1.310
Ashburn 1.300
Izmir 1.235
Beijing 1.230
Jacksonville 1.222
Boardman 1.012
Princeton 831
Shanghai 483
Wilmington 464
San Mateo 446
New York 431
Ann Arbor 399
Helsinki 385
Shenyang 372
Nanchang 353
Hebei 297
Toronto 261
Kunming 241
Jinan 217
Changsha 204
Tianjin 202
Jiaxing 198
Hefei 182
Kocaeli 174
Abidjan 165
Parma 158
Brussels 131
Norwalk 131
Seattle 108
Los Angeles 107
Hangzhou 106
Guangzhou 102
Fremont 92
Pune 86
Zhengzhou 81
Des Moines 72
Bremen 70
Chicago 64
Ningbo 64
Vienna 54
Dallas 49
London 49
Frankfurt am Main 48
Woodbridge 48
Houston 45
Munich 45
Washington 43
Grafing 38
Taizhou 36
Milan 35
Edinburgh 34
Haikou 32
Lanzhou 32
Wuhan 29
Cambridge 28
Borås 27
Melbourne 27
Taiyuan 27
Chengdu 26
Fuzhou 25
Shaoxing 25
Bologna 24
Rockville 24
Ottawa 23
Budapest 22
Leawood 22
Timisoara 20
Xian 20
Chongqing 19
Andover 17
Redmond 17
Changchun 15
Augusta 14
Phoenix 14
Moscow 13
Rio Saliceto 13
Rome 13
Stockholm 13
Brno 12
São Paulo 12
Padova 11
Redwood City 11
Sofia 11
Wenzhou 11
Baotou 10
Bratislava 10
Hong Kong 10
Sydney 10
Tokyo 10
Turin 10
Zanjan 10
Auburn Hills 9
Bucharest 9
Focsani 9
Marseille 9
Totale 30.943
Salva come PNG Salva come JPEG
Nome #
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 130
Approach to gastroenterological diseases in primary care 109
Studio della lattoferrina nel succo pancreatico-duodenale. Limiti nelle diagnosi di pancreatite cronica 106
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 99
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 99
Thyroid and celiac disease in pediatric age: a literature review 97
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 94
How and when investigating and treating Helicobacter pylori infection in children 94
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study 93
Long-term treatment for gastric and duodenal ulcer 93
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 92
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD 92
Endoscopic ultrasound in pediatric population: a comprehensive review of the literature 92
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 91
Gastric and duodenal ulcer in the same patient 90
Individualized treatment of duodenal ulcer disease. A pilot study 90
ASPETTI METODOLOGICI DEL SONDAGGIO GASTRICO 89
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 88
Are 6 days of a triple clarithromycin based therapy sufficient to obtain the cure of H pylori infection? 87
Association of keratin 8 gene mutation with chronic pancreatitis 87
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 87
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 86
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 85
Conservative treatment of acute appendicitis 85
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 84
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 84
Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy 84
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 83
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 83
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 83
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 83
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 82
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 82
Burning Mouth Syndrome Etiology: A Narrative Review 82
Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study 81
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy 81
Autoimmune diseases in autoimmune atrophic gastritis 81
Efficacy of one-week triple therapies with low-dose rabeprazole and clarithromycin plus standard-dose amoxicillin or tinidazole for the cure of H pylori infection in elderly patients 80
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 80
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 80
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 79
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 79
Barrett’s esophagus: results from an Italian cohort with tight endoscopic surveillance 79
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 78
Helicobacter pylori non-cytotoxic genotipe enhances mucosal gastrin and MAST cell triptase 78
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 78
Keratin 8 mutations in patients with chronic pancreatitis 78
Does chronic hypercalcemia influence serum pepsinogens levels? 78
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia 78
Epidemiology and risk factors of pancreatic cancer 78
Advanced gastric cancer: the value of surgery 78
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases 77
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 77
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 77
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 77
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 77
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 77
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 77
Efficacy of 5-ASA in the treatment of colonic diverticular disease 77
Effects of gastroesophageal reflux disease in laryngeal carcinoma 76
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 76
Treatment of Helicobacter pylori infection. 76
Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon 76
Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status 76
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 76
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 76
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 76
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 76
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 76
PPIs plus H2-antagonists for non-responders GERD patients: A rescue therapy? (a three months pilot study) 76
Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology 76
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 76
La Biopsie biochimica gastrica 75
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 75
ACID SUPPRESSION THERAPY: WHERE DO WE FROM HERE? 75
Efficacy of a therapeutic strategy for eradication ofHelicobacter pyloriinfection 75
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 75
THE SLEEPING REMNANT 75
Acid-related disorders in the elderly 75
Accuracy of urea breath tests tablets after 10 minutes compared with standard 30 minutes to diagnose and monitoring helicobacter pylori infection: A randomized controlled trial 75
Reply 75
Follow-up in gastric dysplasia patients 75
Prevalence of H. pylori CagA+ve in suburban area with high incidence of gastric cancer 74
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 74
Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients 74
The Sleeping Remnant. Effect of Roux-En-Y Gastric Bypass on Plasma Levels of Gastric Biomarkers in Morbidly Obese Women: A Prospective Longitudinal Study 74
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 74
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 74
P.05.11 CLINICAL USEFULNESS OF LACTOSE-RESTRICTED DIET IN POSITIVE QUICK LACTASE TEST PATIENTS: PROSPECTIVE 4 MONTHS STUDY 74
Is it possible to withdrawal PPI’s therapy in GERD patients? A prospective study on 216 patients using HYCHSA 73
Usefullness of gastropanel in different topography of H. pylori related chronic gastritis 73
Low-doses versus standard-doses of clarithromicin in combination with amoxycillin and rabeprazole for the eradication of H. pylori infection in elderly subjects 73
A primary-care interventional model on the diverticular disease: Searching for the optimal therapeutic schedule 73
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 73
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 73
OC.18.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM ADMINISTRATION: A 6 MONTHS STUDY IN ATROPHIC GASTRITIS SUBJECTS 73
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 73
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 73
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 73
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 73
Totale 8.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 183.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.854 0 0 0 0 0 1.193 817 184 411 789 173 287
2020/20212.322 47 278 272 18 295 49 260 11 431 235 372 54
2021/20223.602 47 23 52 224 206 59 213 444 176 310 342 1.506
2022/202314.711 1.540 1.337 984 1.304 1.153 1.798 103 1.127 4.622 60 555 128
2023/20244.820 251 577 136 136 414 1.364 214 351 145 282 398 552
2024/20257.167 347 988 1.140 853 1.997 1.842 0 0 0 0 0 0
Totale 45.418